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Poised at the interface between flowing blood and the
vascular wall, the endothelium transduces biological and
physical stimuli within the circulation into physiological
responses that affect vascular and tissue homeostasis. There
currently is great interest in the importance of abnormalities
of endothelial cell function for the development of athero-
sclerosis. When exposed to conditions that mimic cardio-
vascular disease risk factors, cultured endothelial cells adopt
a proinflammatory, pro-thrombotic, vasoconstrictor, and
growth-promoting phenotype that is relevant to atherogen-
esis and cardiovascular disease events (1). Studies in patients
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have shown that endothelial dysfunction, as reflected by
impaired endothelium-dependent vasodilation, is associated
with increased risk for cardiovascular disease events (for a
review, see Widlansky et al. [2]). Serum markers of endo-
thelial activation may provide similar prognostic informa-
tion (2,3). Furthermore, many interventions that improve
endothelial function have been shown to reduce cardiovas-
cular risk, including lipid-lowering therapy, angiotensin-
converting enzyme inhibitors, smoking cessation, and phys-
ical exercise (2). These observations have promoted
speculation that endothelial function may serve as a “ba-
rometer” for the cumulative effects of risk factors and
therapies on vascular health (4).
For many years, investigators have recognized that local
rheologic forces influence endothelial phenotype and impact
atherogenesis. Although the entire arterial tree is exposed to
systemic risk factors, atherosclerosis has a predilection for
branch points and other regions of disordered flow (5). The
effects of local shear stress on endothelial phenotype may
account for this observation (6). In general, laminar shear
stress maintains normal endothelial structure and function,
whereas stasis, turbulent flow, and local shear gradients
activate endothelial cells and induce a pro-atherogenic state
that includes reduced expression of endothelial nitric oxide
synthase (eNOS) and increased expression of vasoconstric-
tor and pro-inflammatory factors (7). The pulsatile pattern
of shear stress also affects the endothelium. Thus, rapidly
changing flow and oscillatory flow with flow reversal and
low net flow tends to induce a more pathologic state
compared with laminar flow or oscillatory flow that remains
unidirectional (7–9). These adverse effects are associated
with increased oxidative stress in the vascular wall (10,11).
However, the compliance of the underlying arterial wall
importantly modulates the consequences of oscillatory flow.
If the artery has normal distensibility, oscillatory flow may
actually be cytoprotective, but the same stimulus has an
adverse effect in a non-compliant vessel (12,13). There also
is evidence that increasing the frequency of pulsations may
be advantageous (14). Finally, higher pulse pressure, which
relates strongly to stiffness of central arterial vessels (15), is
associated with endothelial dysfunction (16). Thus, it is
apparent that arterial flow patterns, vascular compliance,
and pulse pressure may have complex and interacting effects
on endothelial cells and other components of the vascular
wall.
In whole animals and in human subjects, local shear
stress has short- and long-term effects. Acute increases in
arterial flow stimulate release of nitric oxide and other
endothelium-derived relaxing factors that dilate the artery
and restore shear stress toward normal (17). In humans, this
response has been demonstrated in normal coronary arteries
and is impaired in the presence of atherosclerosis (18).
Flow-mediated dilation may be examined non-invasively in
the brachial artery using reactive hyperemia to induce a
transient increase in shear stress (19). Brachial artery flow-
mediated dilation has been shown to depend on nitric oxide
synthesis (20), and an abnormal response may predict
cardiovascular disease events (21). Longer-term increases in
flow produce changes in endothelial shape, alignment, and
the expression of genes associated with a healthy phenotype,
including increased expression of eNOS (5). Furthermore,
increased flow has profound effects on arterial structure,
including increased arterial size through remodeling and
effects on growth of new vessels through angiogenesis (5).
Repetitive short-term increases in flow appear to have
similar beneficial effects and are believed to contribute to the
antiatherosclerotic effects of physical exercise in coronary
(22,23) and peripheral arteries (24).
In this issue of the Journal, Shechter et al. (25) report the
results of a study that examined another intervention that
influences arterial flow and pulsatility and its effects on
endothelial function. External counterpulsation therapy
(ECP) is considered an “alternative” therapy for patients
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with intractable coronary artery disease (for a recent com-
prehensive review, see Bonetti et al. [26]). During ECP,
patients lie supine while cuffs on the lower extremities are
repeatedly inflated in a sequential distal-to-proximal man-
ner during diastole. Thus, ECP induces retrograde flow of
blood from the lower extremities into the central aorta and
produces a large diastolic pressure wave that increases coronary
perfusion pressure and flow in a manner reminiscent of
intra-aortic balloon pumping. This counterpulsation-induced
“reflected wave” represents an exaggeration of the normal
pattern of diastolic wave reflection found in young, healthy
adults (27). Rapid deflation of the cuffs immediately before
systole decreases myocardial afterload and myocardial oxygen
demand. In the arm, flow increases markedly during diastole,
and ECP thereby transiently eliminates exposure to repetitive
and potentially deleterious diastolic stasis or flow reversal (26).
In the reported study, 20 patients with severe coronary artery
disease and intractable angina pectoris received ECP for 1 h
per day, 5 days per week for 7 weeks. As has been previously
reported, the subjects had subjective improvement of angina
symptoms and reported less nitroglycerin use (26). In addition,
brachial artery flow-mediated dilation improved markedly,
whereas the dilator response to sublingual nitroglycerin re-
mained unchanged. A control group of 20 comparable patients
who had declined ECP therapy had no change in symptoms
and no change in vasodilator function over the same period of
time.
As Shechter et al. (25) point out, the major weakness of
the study is the lack of a randomized control group. It is
unclear why the non-randomized control patients declined
therapy and whether there was some other difference be-
tween groups. The study also would have been more
convincing if the control group had received sham therapy.
Shechter et al. (25) do not report the effect of ECP on
baseline brachial artery diameter, and because flow-
mediated dilation relates strongly to this variable, it is
possible the results reflect an effect of treatment on resting
arterial tone or vessel size, rather than conduit artery
endothelial vasodilator function. Furthermore, the investi-
gators did not examine the effect of therapy on the extent of
reactive hyperemia, which determines the evoked shear
stress in the brachial artery and, thus, serves as the stimulus
to flow-mediated dilation. It remains distinctly possible that
ECP had an effect on resistance vessels, rather than the
conduit brachial artery. A preliminary study does suggest
that ECP improves function of small vessels in the finger
during reactive hyperemia (28). Indeed, the potential effects
of increased flow on coronary microvascular function, re-
modeling, and angiogenesis, leading to improved collateral
flow are believed to be important mechanisms of benefit for
ECP (26).
Despite these limitations, the study represents an inter-
esting examination of the physiologic consequences of
altered pulsatility and flow on conduit arteries, and several
potential mechanisms might be considered. As occurs dur-
ing upper extremity exercise, ECP increases upper extremity
blood flow, and this effect has the potential to increase
eNOS expression and improve endothelial function in the
conduit brachial artery. The ECP therapy doubles the
number of arterial pulsations per cardiac cycle, which could
be beneficial given the relationship between pulsation fre-
quency and endothelial function (14). Aging, hypertension,
and other forms of cardiovascular disease are associated with
increased stiffness of the central aorta, and as a result, flow
in the brachial artery becomes more oscillatory and flow
reversal may occur during diastole (15). The ECP therapy
has the potential to markedly augment forward flow during
diastole and limit flow reversal, and this altered flow pattern
could in itself have a beneficial effect.
In summary, the study by Shechter et al. (25) provides
additional evidence that ECP relieves angina symptoms in
patients with severe coronary artery disease and supports the
hypothesis that improved endothelial function is a mecha-
nism of benefit. Further studies would be required to
confirm that this effect has occurred in the coronary circu-
lation and to determine whether improvement of endothe-
lial function in this fashion has any effect on cardiovascular
events in these high-risk patients. An interesting additional
implication of the study relates to rheologic consequences of
ECP. It is now clear that the various forms of local shear
stress and the pulsatile patterns of flow and blood pressure
have important effects on the vasculature and the heart that
are relevant to cardiovascular disease. The vascular endo-
thelium plays a major role in transducing these physical
forces into adaptive physiologic responses, and loss of these
homeostatic mechanisms is an important consequence of
endothelial dysfunction that merits investigation and serves
as a target for therapy.
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